'Problem patients and physicians' failures': What it means for doctors to counsel vaccine hesitant patients in Switzerland.

Adherence and compliance Good and bad doctors Good and bad patients Patient-provider interactions Problem patients Switzerland Underimmunization Vaccine hesitancy

Journal

Social science & medicine (1982)
ISSN: 1873-5347
Titre abrégé: Soc Sci Med
Pays: England
ID NLM: 8303205

Informations de publication

Date de publication:
06 2020
Historique:
received: 02 09 2019
revised: 16 03 2020
accepted: 19 03 2020
pubmed: 21 4 2020
medline: 28 4 2021
entrez: 21 4 2020
Statut: ppublish

Résumé

This article reports on our qualitative inquiry into the meanings biomedically trained doctors in Switzerland attach to treating vaccine hesitant (VH) and underimmunized patients. With support from social science literature on 'good' and 'bad' patients and doctors, we explore how both doctors and patients cross the boundaries of these conceptual categories in situations involving vaccine hesitancy and underimmunization. The doctors we interviewed (N = 20) and observed (N = 16 observations, subsample of 6 doctors from the interview sample) described how they screened, measured, and diagnosed patients' levels of vaccine hesitancy. Our results emphasize the meanings doctors associated with counseling hesitant patients, especially while managing their own professional responsibilities, legitimacy, and reputations among colleagues and patients. Doctors' discourses constructed the figure of 'problem patients,' characterized through their (potential) non-adherence to vaccination recommendations, desire for lengthy consultations and individualized counseling, and dogmatic ideologies running contra to biomedicine. Discussions around the dilemmas faced by doctors in vaccination consultations brings to the fore several key, yet underdiscussed, paradoxes concerning VH, patient-doctor relationships, and the constructs of 'good'/'bad' doctors and patients. These paradoxes revolve around expectations in Western societies for 'good' patients to be autonomous health-information seekers and active participants in clinical encounters, which research shows to be the case for many VH and underimmunizing individuals. However, in the eyes of many vaccination advocates and proponents of biomedical approaches, VH patients become 'bad' patients thru their risk of non-adherence, which has implications for the population at large. In these consultations, doctors find themselves conflicted around the expectations to promote vaccination while, at the same time, being active listeners and good communicators with those who question their biomedical training and legitimacy. Understanding these paradoxes highlights the need to better support HCPs in addressing VH in clinical practice.

Identifiants

pubmed: 32311515
pii: S0277-9536(20)30165-9
doi: 10.1016/j.socscimed.2020.112946
pii:
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112946

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Michael J Deml (MJ)

Swiss Tropical and Public Health Institute (Swiss TPH), Socinstrasse 57, 4051, Basel, Switzerland; University of Basel, Petersplatz 1, 4001, Basel, Switzerland. Electronic address: michael.deml@swisstph.ch.

Andrea Buhl (A)

Swiss Tropical and Public Health Institute (Swiss TPH), Socinstrasse 57, 4051, Basel, Switzerland; University of Basel, Petersplatz 1, 4001, Basel, Switzerland. Electronic address: andrea.buhl@unibas.ch.

Julia Notter (J)

University of Basel, Petersplatz 1, 4001, Basel, Switzerland; University Department of Medicine, Kantonsspital Baselland, University of Basel, 4101, Bruderholz, Switzerland. Electronic address: julia.notter@kssg.ch.

Paulina Kliem (P)

University of Basel, Petersplatz 1, 4001, Basel, Switzerland; University Department of Medicine, Kantonsspital Baselland, University of Basel, 4101, Bruderholz, Switzerland. Electronic address: paulina.kliem@stud.unibas.ch.

Benedikt M Huber (BM)

Department of Pediatrics, Fribourg - Kantonsspital, Chemin des Pensionnats 2-6, 1708, Fribourg, Switzerland. Electronic address: Benedikt.huber@h-fr.ch.

Constanze Pfeiffer (C)

Swiss Tropical and Public Health Institute (Swiss TPH), Socinstrasse 57, 4051, Basel, Switzerland; University of Basel, Petersplatz 1, 4001, Basel, Switzerland. Electronic address: constanze.pfeiffer@unibas.ch.

Claudine Burton-Jeangros (C)

Institute of Sociological Research, University of Geneva, Bd. du Pont-d'Arve 40, 1211, Geneva 4, Switzerland. Electronic address: claudine.jeangros@unige.ch.

Philip E Tarr (PE)

University of Basel, Petersplatz 1, 4001, Basel, Switzerland; University Department of Medicine, Kantonsspital Baselland, University of Basel, 4101, Bruderholz, Switzerland. Electronic address: philip.tarr@unibas.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH